Fig. 2From: Real-world effectiveness of omalizumab for severe allergic asthma treatment in ColombiaComparison of annualized clinically significant exacerbation rates. A reduction of the annualized rate of clinically significant exacerbation was observed between the observed periods before and after Omalizumab use (n = 143)Back to article page